Skip to content

Hitachi HIT Deferred offering costs

Deferred offering costs at other companies

Hitachi logo
HitachiHIT
$170.98K
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$164.72K
NextNRG, Inc. Common Stock logo
NextNRG, Inc. Common StockNXXT
$18.09K-98.8%
DeFi Development Corp. Common Stock logo
DeFi Development Corp. Common StockDFDV
$3.36M+2,861%
ROC
Rank One Computing ROC
$226.8K
Bain Capital Specialty Finance logo
Bain Capital Specialty FinanceBCSF
$3.29M-24.2%

Other financials

Income statement

See full
Revenue$8.8M+9.4%
Gross profit$4.5M-15.8%
Net income-$1.6M-419%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$10.3M+36.3%
Total debt$121.6K-36.2%
Total equity$21.6M+52.6%
Total assets$29.0M+35.8%

Cash flow

See full
Operating cash flow-$3.3M-729%

Valuation

See full
Market cap$66.21M+51.3%
Enterprise value$56.01M+56.5%
P/S1.9×+0.3×

Profitability

See full
Gross margin58.9%-15.5pp
Net margin9.3%

Returns & leverage

See full
Return on equity105.4%
Debt / equity0.0×
Current ratio3.1×+0.8×

Where this comes from

Reported directly by Hitachi in its filing.

Tagged under the XBRL concept us-gaap:DeferredOfferingCosts.

The official record: Hitachi’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hitachi's deferred offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hitachi's deferred offering costs?
Hitachi (HIT) reported deferred offering costs of $170.98K in Q4 2025.
What does deferred offering costs mean?
These represent direct incremental costs incurred in connection with a proposed issuance of equity or debt securities. These costs are deferred on the balance sheet until the offering is successfully completed, at which point they are reclassified as a reduction of the proceeds. If the offering is aborted, these costs are typically expensed immediately.